BG45
BG45 is a small molecule which can act as a HDAC3 selective inhibitor. It is provided as a powder.
This product acts on the following target types: Protein deacetylase.
This product acts on the following biochemical pathways: Myc, Posttranslational modification.
This product may be interest in the following research areas and diseases: Epigenetics, Neuroscience, Neurodegeneration, Cancer.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
This product acts on the following target types: Protein deacetylase.
This product acts on the following biochemical pathways: Myc, Posttranslational modification.
This product may be interest in the following research areas and diseases: Epigenetics, Neuroscience, Neurodegeneration, Cancer.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx283384-5MG |
| Pricing | 5 mg USD $152.25 |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| Note |
|
| CAS Number | 926259-99-6 |